Literature DB >> 11130225

Anaphylactoid reaction to levofloxacin.

M A Smythe1, D M Cappelletty.   

Abstract

Anaphylactoid and/or anaphylactic reactions to fluoroquinolones are estimated to occur in 0.46-1.2/100,000 patients. A 49-year-old woman with a history of asthma was admitted for a presumed asthma exacerbation related to an infectious process. She was given levofloxacin and standard management for an acute exacerbation. On two occasions the patient's respiratory distress worsened, requiring intubation. The second reaction occurred immediately after levofloxacin administration and was accompanied by a marked cutaneous reaction. Levofloxacin was discontinued, and supportive care was provided. No further symptoms occurred. The patient later was found to have been started on levofloxacin before admission for a suspected upper respiratory infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11130225     DOI: 10.1592/phco.20.19.1520.34868

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

1.  Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.

Authors:  Roberto Leone; Anita Conforti; Mauro Venegoni; Domenico Motola; Ugo Moretti; Ilaria Meneghelli; Alfredo Cocci; Giulia Sangiorgi Cellini; Stefania Scotto; Nicola Montanaro; Giampaolo Velo
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Incidence of allergic reactions associated with antibacterial use in a large, managed care organisation.

Authors:  Catherine B Johannes; Najat Ziyadeh; John D Seeger; Ed Tucker; Christoph Reiter; Gerald Faich
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  A case of levofloxacin-induced anaphylaxis with elevated serum tryptase levels.

Authors:  Ji-Ho Lee; Won Yeon Lee; Suk Joong Yong; Kye Chul Shin; Myoung Kyu Lee; Chong Whan Kim; Sang-Ha Kim
Journal:  Allergy Asthma Immunol Res       Date:  2012-11-07       Impact factor: 5.764

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.